Trial Profile
Phase I trial of AGN 209323 [EHT/AGN 001] in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2010
Price :
$35
*
At a glance
- Drugs AGN 209323 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Allergan